Summary: Striking antibody evasion by emerging circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants drives the identification of broadly neutralizing antibodies (bNAbs). However. how a bNAb acquires increased neutralization breadth during antibody evolution is still elusive. Here. https://www.remtavares.com/